Moderator: Dr. Christopher Lawrence, Director, Medical Affairs | Thermo Fisher Scientific
Guest Speaker: Georg Böhmig, MD | Medical University of Vienna • Vienna, Austria
With a future effective LCD announced for molecular testing for solid organ allograft rejection, clinicians may now consider applying molecular gene expression profiling in a variety of clinical cases. In this presentation, Dr. Böhmig explores the use of MMDx-Kidney and MMDx-Heart for the management of post-transplant kidney and heart patients. A variety of case studies are presented where molecular assessment was applied to diagnose allograft dysfunction and to determine if rejection was due to antibody-mediated rejection (ABMR), T-cell-mediated rejection (TCMR), or a combination of both.
Please sign in to access your account. Customers must log in to access some content, recorded webinars, training materials, documents, and software.
Please provide the following to setup your user account. If you do not know your center ID, please leave the center ID field blank.